Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Current Opinion in Biotechnology
|
May 22, 2012
Killed but metabolically active vaccines
Thomas W Dubensky, Justin Skoble, Peter Lauer, et al.
Infection and Immunity
|
January 27, 2009
Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax
Justin Skoble, John W Beaber, Yi Gao, et al.
Infection and Immunity
|
June 11, 2008
Constitutive Activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains
Peter Lauer, Bill Hanson, Edward E Lemmens, et al.
Infection and Immunity
|
June 26, 2019
A Potent and Effective Suicidal <i>Listeria</i> Vaccine Platform
William G Hanson, Erin L Benanti, Edward E Lemmens, et al.
Oncotarget
|
October 6, 2025
ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response
Kyle R Cron, Ping Fang, Oanh Pham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2015
Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer
Dung T Le, Andrea Wang-Gillam, Vincent Picozzi, et al.
Cytotherapy
|
April 22, 2023
Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitness
Elaine Lau, George Kwong, Tristan W Fowler, et al.
Cancer Immunology Research
|
February 12, 2024
High-Specificity CRISPR-Mediated Genome Engineering in Anti-BCMA Allogeneic CAR T Cells Suppresses Allograft Rejection in Preclinical Models
Émilie Degagné, Paul D Donohoue, Suparna Roy, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Current Opinion in Biotechnology
|
May 22, 2012
Killed but metabolically active vaccines
Thomas W Dubensky, Justin Skoble, Peter Lauer, et al.
Infection and Immunity
|
January 27, 2009
Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax
Justin Skoble, John W Beaber, Yi Gao, et al.
Infection and Immunity
|
June 11, 2008
Constitutive Activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains
Peter Lauer, Bill Hanson, Edward E Lemmens, et al.
Infection and Immunity
|
June 26, 2019
A Potent and Effective Suicidal <i>Listeria</i> Vaccine Platform
William G Hanson, Erin L Benanti, Edward E Lemmens, et al.
Oncotarget
|
October 6, 2025
ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response
Kyle R Cron, Ping Fang, Oanh Pham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2015
Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer
Dung T Le, Andrea Wang-Gillam, Vincent Picozzi, et al.
Cytotherapy
|
April 22, 2023
Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitness
Elaine Lau, George Kwong, Tristan W Fowler, et al.
Cancer Immunology Research
|
February 12, 2024
High-Specificity CRISPR-Mediated Genome Engineering in Anti-BCMA Allogeneic CAR T Cells Suppresses Allograft Rejection in Preclinical Models
Émilie Degagné, Paul D Donohoue, Suparna Roy, et al.
Page
of 1